“…It has also been reported in the clinical setting of hypocholesterolemia, hypomagnesaemia, hypercalcemia, aluminum overload, high-dose methylprednisolone therapy, uremic encephalopathy, pheochromocytoma, systemic lupus erythematosus, Henoch-Schönlein purpura, acute hepatic failure, thrombotic thrombocytopenic purpura, and human immunodeficiency virus infection by some investigators. 4 The exact pathophysiology has yet not been elucidated. It has been postulated that the clinical features might be due to sudden disruption of the autoregulatory mechanisms of the central nervous system vasculature, leading to vasoconstriction and vasodilatation, resulting in endothelial dysfunction and breakdown of the blood-brain barrier.…”